Benchmark Holdings (Benchmark Holdings) Days Sales Outstanding : 90.94 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Benchmark Holdings Days Sales Outstanding?

Benchmark Holdings's average Accounts Receivable for the three months ended in Dec. 2023 was $51.1 Mil. Benchmark Holdings's Revenue for the three months ended in Dec. 2023 was $51.2 Mil. Hence, Benchmark Holdings's Days Sales Outstanding for the three months ended in Dec. 2023 was 90.94.

The historical rank and industry rank for Benchmark Holdings's Days Sales Outstanding or its related term are showing as below:

BHCCF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 52.34 Med: 77.86 Max: 116.23
Current: 107.39

During the past 12 years, Benchmark Holdings's highest Days Sales Outstanding was 116.23. The lowest was 52.34. And the median was 77.86.

BHCCF's Days Sales Outstanding is ranked worse than
77.86% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.845 vs BHCCF: 107.39

Benchmark Holdings's Days Sales Outstanding increased from Dec. 2022 (65.08) to Dec. 2023 (90.94).

Benchmark Holdings Days Sales Outstanding Historical Data

The historical data trend for Benchmark Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benchmark Holdings Days Sales Outstanding Chart

Benchmark Holdings Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Days Sales Outstanding

Get a 7-Day Free Trial

119.64

86.09

51.19

63.87

54.81

Benchmark Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															65.08	102.61	125.70	92.48	90.94

Competitive Comparison of Benchmark Holdings's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Benchmark Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Benchmark Holdings's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Benchmark Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Benchmark Holdings's Days Sales Outstanding falls into.

Benchmark Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Benchmark Holdings's Days Sales Outstanding for the fiscal year that ended in Sep. 2023 is calculated as

	Days Sales Outstanding (A: Sep. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2022 )	+	Accounts Receivable (A: Sep. 2023 ))	/	count )	/	Revenue (A: Sep. 2023 )	*	Days in Period
=	( (32.242	+	30.752)	/	2 )	/	209.748	*	365
=	31.497					/	209.748	*	365
=	54.81

Benchmark Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (30.752	+	71.367)	/	2 )	/	51.232	*	365 / 4
=	51.0595					/	51.232	*	365 / 4
=	90.94

Benchmark Holdings (OTCPK:BHCCF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Benchmark Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Benchmark Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Benchmark Holdings (Benchmark Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Benchmark Holdings PLC (OTCPK:BHCCF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

BMK:Norway BMK:UK 31B:Germany

Address

Yeoman Way, Highdown House, Worthing, West Sussex, GBR, BN99 3HH

Website

https://www.benchmarkplc.com

Benchmark Holdings PLC is engaged in the healthcare sector. Its operating segment includes Genetics; Advanced Nutrition; Health; and Corporate. The company generates maximum revenue from the Advanced Nutrition segment. The Advanced Nutrition segment manufactures and provides technically advanced nutrition and health products to the aquaculture industry. Geographically, it derives a majority of its revenue from Norway and also has a presence in Vietnam; the Faroe Islands; Ecuador; India; Greece; Canada; Chile, and the Rest of World.

Benchmark Holdings (Benchmark Holdings) Headlines

From GuruFocus

Q1 2024 Benchmark Holdings PLC Earnings Presentation Transcript

By GuruFocus Research • 02-28-2024